Literature DB >> 10537274

Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.

H Sjögren1, J Meis-Kindblom, L G Kindblom, P Aman, G Stenman.   

Abstract

Extraskeletal myxoid chondrosarcomas (EMCs) are characterized by a recurrent t(9;22)(q22;q12) translocation, resulting in the fusion of the EWS gene in 22q12 and the TEC gene in 9q22. Here we report that a third member of the EWS, TLS/FUS gene family, TAF2N, can replace EWS as a fusion partner to TEC in EMC. Two tumors, one with a novel t(9;17)(q22;q11) variant translocation and one with an apparently normal karyotype, expressed TAF2N-TEC fusion transcripts. In both cases, the chimeric transcripts were shown to contain exon 6 of TAF2N fused to the entire coding region of TEC. This transcript is structurally and functionally very similar to the EWS-TEC fusions. The exchange of the EWS NH2-terminal part with the TAF2N NH2-terminal part in EMC further underscores the oncogenic potential of these protein domains as partners in fusion genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537274

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Identification of genes regulated by the EWS/NR4A3 fusion protein in extraskeletal myxoid chondrosarcoma.

Authors:  Christine Filion; Yves Labelle
Journal:  Tumour Biol       Date:  2012-05-18

2.  Extraskeletal myxoid chondrosarcoma metastatic to the pancreas: a case report.

Authors:  C Fotiadis; A Charalambopoulos; S Chatzikokolis; G C Zografos; M Genetzakis; R Tringidou
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 3.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

4.  Rhabdoid Variant of Myoepithelial Carcinoma, with EWSR1 Rearrangement: Expanding the Spectrum of EWSR1-Rearranged Myoepithelial Tumors.

Authors:  Khin Thway; Nick Bown; Aisha Miah; Rob Turner; Cyril Fisher
Journal:  Head Neck Pathol       Date:  2014-07-04

5.  Extraskeletal myxoid chondrosarcoma of the thigh with a t(9;17) translocation.

Authors:  Taketoshi Yasuda; Takeshi Hori; Kayo Suzuki; Masahiko Kanamori; Shigeharu Nogami; Yasuhito Yahara; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2011-12-19       Impact factor: 2.967

Review 6.  Molecular pathology of chondroid neoplasms: part 2, malignant lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-10-18       Impact factor: 2.199

Review 7.  The benefits of molecular pathology in the diagnosis of musculoskeletal disease : part I of a two-part review: soft tissue tumors.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2010-02       Impact factor: 2.199

Review 8.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

9.  The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.

Authors:  C Filion; T Motoi; A B Olshen; M Laé; R J Emnett; D H Gutmann; A Perry; M Ladanyi; Y Labelle
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

10.  Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.

Authors:  Narasimhan P Agaram; Lei Zhang; Yun-Shao Sung; Samuel Singer; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-01-28       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.